Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP27749.RAVxB6AKIvLEbK_EVf-ohRTyhSwlwWVc7EnXXzUHMwh9M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP27749.RAVxB6AKIvLEbK_EVf-ohRTyhSwlwWVc7EnXXzUHMwh9M130_assertion type Assertion NP27749.RAVxB6AKIvLEbK_EVf-ohRTyhSwlwWVc7EnXXzUHMwh9M130_head.
- NP27749.RAVxB6AKIvLEbK_EVf-ohRTyhSwlwWVc7EnXXzUHMwh9M130_assertion description "[In inflammatory bowel disease, increased production of prostaglandins by cyclooxygenase-2 (COX-2) contributes to bowel dysfunction, inflammatory edema, and hyperemia suggesting that inhibitors of COX-2 may have beneficial effect in gut inflammation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27749.RAVxB6AKIvLEbK_EVf-ohRTyhSwlwWVc7EnXXzUHMwh9M130_provenance.
- NP27749.RAVxB6AKIvLEbK_EVf-ohRTyhSwlwWVc7EnXXzUHMwh9M130_assertion evidence source_evidence_curated NP27749.RAVxB6AKIvLEbK_EVf-ohRTyhSwlwWVc7EnXXzUHMwh9M130_provenance.
- NP27749.RAVxB6AKIvLEbK_EVf-ohRTyhSwlwWVc7EnXXzUHMwh9M130_assertion SIO_000772 11820457 NP27749.RAVxB6AKIvLEbK_EVf-ohRTyhSwlwWVc7EnXXzUHMwh9M130_provenance.
- NP27749.RAVxB6AKIvLEbK_EVf-ohRTyhSwlwWVc7EnXXzUHMwh9M130_assertion wasDerivedFrom ctd_human-20130708 NP27749.RAVxB6AKIvLEbK_EVf-ohRTyhSwlwWVc7EnXXzUHMwh9M130_provenance.
- NP27749.RAVxB6AKIvLEbK_EVf-ohRTyhSwlwWVc7EnXXzUHMwh9M130_assertion wasGeneratedBy ECO_0000218 NP27749.RAVxB6AKIvLEbK_EVf-ohRTyhSwlwWVc7EnXXzUHMwh9M130_provenance.